KEGG   DRUG: Budesonide and formoterol fumarate dihydrateHelp
Entry
D09595            Mixture   Drug                                   

Name
Budesonide and formoterol fumarate dihydrate;
Symbicort (TN)
Product
Component
Budesonide [DR:D00246], Formoterol fumarate [DR:D05277]
Remark
Therapeutic category: 2290
ATC code: R03AK07
Product: D09595<JP/US>
Efficacy
Antiasthmatic
  Disease
Asthma [DS:H00079]
Chronic obstructive pulmonary disease [DS:H01714]
Comment
Budesonide is primarily metabolized by CYP3A4.
Formoterol is primarily metabolized by UDP-glucuronosyltransferase (UGT).
Metabolism
Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
     R03AK07 Formoterol and budesonide
      D09595  Budesonide and formoterol fumarate dihydrate <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Bronchodilators, Other
   Budesonide/ Formoterol Fumarate Dihydrate
    D09595  Budesonide and formoterol fumarate dihydrate
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D09595  Budesonide and formoterol fumarate dihydrate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D09595
BRITE hierarchy
Other DBs
PubChem: 124490335
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system